MHC 750 JH 01 Direct To Consumer Drug Advertising


Published on

Published in: Health & Medicine
  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide
  • MHC 750 JH 01 Direct To Consumer Drug Advertising

    1. 1. Direct-To-Consumer Advertising : Is It Creating Well-Informed or Mislead, Unduly Influenced Patients? Donna Doherty Jeanne Ulmer Leslie Pirtle MHC 750 JH01 March 2008
    2. 2. Introduction <ul><li>Youtube Act 1 </li></ul><ul><li>Youtube Act 2 </li></ul>
    3. 3.
    4. 4. 1985 FDA issues Guidelines FDA requests voluntary Moratorium 1982 1st D-T-C Rx drug ad in US 1981 13.5% D-T-C ads are on TV 1994 FDA relaxes rules governing TV ads 1997 2000 63.8% D-T-C ads are on TV
    5. 5. FDA Oversight <ul><li>The FDA regulates the promotion of prescription drugs, including the content of DTC advertisements </li></ul><ul><li>Requires that advertisements present accurate information and fairly represent both the benefits and risks of the drugs being advertised </li></ul><ul><li>In 1997 the FDA issued draft guidance to clarify and offer options on how these regulations applied to DTC advertisements on radio and television. </li></ul><ul><li>FDA reviews ads that will reach a wide audience-this includes all TV ads </li></ul><ul><li>Sent warning letters to violating companies for 5% of ads between 97 and 00 </li></ul>
    6. 6. Spending on DTCA 1997-2005 Table 1: Prescription Drug Promotion and Research and Development, 1997-2005. (Source: U.S. Government Accountability Office, Prescription Drugs: Improvements Needed in FDA's Oversight of Direct-to-Consumer Advertising ', GAO report Number GAO-07-54, December 14, 2006.  103.3 162.4 86.0 296.4 Total % increase, ‘97-’05 9.3 14.9 9.0 19.6 Avg annual % increase $31.4 not available $7.2 $4.2 2005 $29.8 $15.9 $7.8 $4.0 2004 $27.1 $13.5 $7.4 $3.3 2003 $21.4 $8.5 $5.6 $2.5 2000 $15.5 $6.0 $3.9 $1.1 1997 R & D Retail value of samples Spending on promotion to physicians Spending on DTC advertising Year
    7. 7. Some Facts <ul><li>&quot;Up until 1997, manufacturers could not say both the product's name and what it was used for, in a TV ad&quot; </li></ul><ul><li>Today, over 196-million consumers have seen a DTC advertisement </li></ul>
    8. 8., p.3
    9. 9. TV Drug Ads Legal In Only 2 Countries <ul><li>New Zealand </li></ul><ul><li>United States </li></ul>
    10. 10. Types of D-T-C Ads <ul><li>Product-claim ads </li></ul><ul><li>Reminder ads </li></ul><ul><li>Help-seeking ads </li></ul>
    11. 11.
    12. 12.
    13. 13. 2 Types of Data <ul><li>Impact of D-T-C advertising on patients </li></ul><ul><li>Impact of D-T-C advertising on physicians </li></ul>
    14. 14.
    15. 15. Pro Direct-To-Consumer <ul><li>Educates Patients </li></ul><ul><li>Prompts to see physician </li></ul><ul><li>Prompts patients to talk about conditions they might not otherwise talk or know about </li></ul><ul><li>Freedom of speech—can’t stop it </li></ul><ul><li>Ultimately reduces costs by prompting early treatment </li></ul><ul><li>Alerts patients to disease they were unaware that they had </li></ul><ul><li>Empowers consumer to become more active participant in their own care </li></ul>
    16. 16. Pro Arguments-Consumers <ul><li>Nearly  two-thirds of consumers agree that DTC advertising is done responsibly </li></ul><ul><li>Approximately two-thirds of consumers have talked with their doctors about a prescription drug as a result of DTC advertising.  </li></ul><ul><li>Approximately 20-million have had three or more of these conversations </li></ul><ul><li>2002/1 in 5 Americans were prompted to contact MD to discuss a D-T-C advertised drug (Gottlieb,BMJ,2002) </li></ul><ul><li>1999, 15.3 million Americans requested D-T-C advertised drugs/12.9 million received the drug,(Mintzes,2001) </li></ul>
    17. 17. Pro Arguments-Doctors <ul><li>Facilitates patient-provider communication </li></ul><ul><li>Prompts patients to discuss symptoms more openly </li></ul><ul><li>41%of MD’s reported improvement in patient awareness of treatment as well as improved discussion, (Aikin et al,2004) </li></ul><ul><li>39% of 643 MD’s prescribed a drug requested by a patient as a result of an advertisement </li></ul><ul><li>46% of the MD’s who had prescribed a patient requested drug felt it was the most effective treatment for the patient’s condition (Health Affairs,4/04) </li></ul><ul><li>Promotes need for MD’s to remain educated about drugs to inform patients </li></ul><ul><li>Prompted patients to see their physician </li></ul><ul><li>Strengthens provider-patient bond </li></ul>
    18. 18. Pro Arguments-Rx Industry <ul><li>Its patients right to know and choose </li></ul><ul><li>Empowers patients w/information </li></ul><ul><li>Urge patients to seek treatment </li></ul><ul><li>Promotes early treatment and diagnosis and reduces spending on medical services such as hospitalization </li></ul>
    19. 19. DTC communications about prescription medicines serve the public health by: <ul><li>Increasing awareness about diseases </li></ul><ul><li>Educating patients about treatment options </li></ul><ul><li>Motivating patients to contact their physicians & engage in a dialogue about health concerns </li></ul><ul><li>Increasing the likelihood that patients will receive appropriate care for conditions that are frequently under-diagnosed and under-treated </li></ul><ul><li>Encouraging compliance with prescription drug treatment regimens. </li></ul>
    20. 20. The Pharmaceutical Research and Manufacturers of America (PhRMA) <ul><li>Premise of the Principles </li></ul><ul><li>Compliance with FDA Regulations </li></ul><ul><li>Responsible Education about the Medicine and/or Health Condition </li></ul><ul><li>Clear Indication that the Medicine is a Prescription Drug </li></ul><ul><li>Encouragement of Communication between Patients and Health Care Providers </li></ul><ul><li>Education of Health Care Providers Prior to Launch of Advertising Campaign </li></ul><ul><li>Alteration or Discontinuation of an Advertising Campaign </li></ul>
    21. 21. The Pharmaceutical Research and Manufacturers of America (PhRMA) <ul><li>Submission of DTC Television Advertisements to the FDA Prior to Broadcast </li></ul><ul><li>Information on Other Treatment Options </li></ul><ul><li>Information about the Medicine’s Approved Purpose and Major Risks </li></ul><ul><li>Balanced Representation of Benefits and Risks </li></ul><ul><li>Respect for the Seriousness of the Medicine and Health Condition </li></ul><ul><li>Avoiding Audiences that are Not Age-Appropriate </li></ul><ul><li>Promotion of Health and Disease Awareness </li></ul><ul><li>Information about Help for the Uninsured and Underinsured </li></ul>
    22. 22. Cons… <ul><li>Appeals to emotions </li></ul><ul><li>Misleading </li></ul><ul><li>Understates risks & side effects </li></ul><ul><li>Benefits are overstated </li></ul><ul><li>Influences patients to ask for meds they don’t need </li></ul><ul><li>Spend money on brand names </li></ul>
    23. 23. Cons… <ul><li>Conditions that aren’t conditions </li></ul><ul><li>physicians under pressure to prescribe drugs unnecessarily. </li></ul><ul><li>Undermines physician-patient agency relationship </li></ul><ul><li>Bribery from drug companies </li></ul>
    24. 24. Cons… <ul><li>Telling healthy patients they are sick! </li></ul><ul><li>Consumers lack the safety and efficacy information they need to make informed decisions </li></ul><ul><li>FDA oversight is too weak </li></ul>
    25. 25. Prevention vs Risk Reduction
    26. 26. Making Health Decisions Based On TV…
    27. 27. US$1.20 US$2.20 US$3.20 US$4.20 Its Quiz Time...
    28. 28. In the year 2000, how much did each dollar spent on direct-to-consumer advertising of prescription drugs in the United States yield in additional pharmaceutical sales? <ul><li>US $1.20 </li></ul><ul><li>US $2.20 </li></ul><ul><li>US $3.20 </li></ul><ul><li>US $4.20 </li></ul>
    29. 29. <ul><li>26% </li></ul>Based on the 2003 European guidelines on cardiovascular disease prevention, what proportion of Norwegian adults would be labeled as having an “unfavorable” cardiovascular risk profile? <ul><li>56% </li></ul><ul><li>76% </li></ul>
    30. 30. <ul><li>US $25 million </li></ul><ul><li>US $85 million </li></ul><ul><li>US $125 million </li></ul>How much did drug companies spend in 2004 in Europe on “disease awareness” campaigns (unbranded disease-specific consumer advertising)?
    31. 31. <ul><li>20% </li></ul>The Pfizer Web site states that sildenafil (Viagra) “works” for what proportion of men? <ul><li>40% </li></ul><ul><li>60% </li></ul><ul><li>80% </li></ul><ul><li>100% </li></ul>
    32. 32. <ul><li>10%–20% of the time </li></ul><ul><li>50%–60% of the time </li></ul><ul><li>80%–90% of the time </li></ul>On its Web site, Pfizer states, “VIAGRA can work for you. In fact, studies show that VIAGRA works for more than 80% of men with ED [erectile dysfunction] taking VIAGRA 100 mg versus 24% of men taking a sugar pill” ?
    33. 33. <ul><li>Men between the ages of 18 and 45 years </li></ul><ul><li>Men between the ages of 45 and 60 years </li></ul><ul><li>Men over 60 years </li></ul>Between 1998 and 2002, the group showing the largest increase in Viagra use was men between the ages of 18 and 45, and only one-third of these men had a possible etiologic reason for needing Viagra
    34. 34. <ul><li>There is good evidence from long-term studies that these drugs can improve the quality of life of people with Alzheimer disease </li></ul><ul><li>Memantine is a good option for all patients with Alzheimer disease </li></ul><ul><li>Donepezil, galantamine, and rivastigmine should be reserved only for people with Alzheimer disease of moderate severity (i.e., those with a Mini-Mental State Examination (MMSE) score between ten and 20) </li></ul>Which of the following best reflects the latest Appraisal Consultation Document from the United Kingdom National Institute for Health and Clinical Excellence (NICE) on prescribing cholinesterase inhibitors?
    35. 35. <ul><li>The drug has been approved in Europe, Australia, and the US </li></ul><ul><li>The European Medicines Evaluation Agency refused to approve fluoxetine for PMDD </li></ul><ul><li>The Australian federal government agreed to cover the costs of Sarafem </li></ul><ul><li>Eli Lilly's advertising of Sarafem has never been in violation of US law </li></ul>Which of the following is true about fluoxetine (Sarafem), a treatment for “premenstrual dysphoric disorder” (PMDD)?
    36. 36. <ul><li>13% </li></ul><ul><li>23% </li></ul><ul><li>33% </li></ul><ul><li>43% </li></ul>According to a widely cited 1999 study in the Journal of the American Medical Association on the prevalence of female sexual dysfunction by Laumann and colleagues, what proportion of women aged 18–59 years suffers from female sexual dysfunction?
    37. 37. <ul><li>Pfizer attempted to have sildenafil (Viagra) approved to treat female sexual arousal disorder, but its quest ended because of consistently poor clinical trial results </li></ul><ul><li>There are no reports of Viagra being prescribed to women off label </li></ul><ul><li>In 2004, an FDA advisory panel voted unanimously to approve a testosterone patch for women (Intrinsa) to treat “hypoactive sexual desire disorder” </li></ul>Which one of the following statements is true about drug treatments for female sexual dysfunction?
    38. 38. Warning…..This lecture has been known to cause hair raising experiences in a small percentage of the population. If this side effect should occur seek the advice of a professional Beautician immediately or visit your doctor and ask for a DTC drug!